2013
DOI: 10.1371/journal.pone.0084419
|View full text |Cite
|
Sign up to set email alerts
|

Targeting Human Telomeric G-Quadruplex DNA and Inhibition of Telomerase Activity With [(dmb)2Ru(obip)Ru(dmb)2]4+

Abstract: Inhibition of telomerase by inducing/stabilizing G-quadruplex formation is a promising strategy to design new anticancer drugs. We synthesized and characterized a new dinuclear complex [(dmb)2Ru(obip)Ru(dmb)2]4+ (dmb = 4,4’-dimethyl-2,2’-bipyridine, obip = (2-(2-pyridyl)imidazo[4,5-f][1,10]phenanthroline) with high affinity for both antiparallel and mixed parallel / antiparallel G-quadruplex DNA. This complex can promote the formation and stabilize G-quadruplex DNA. Dialysis and TRAP experiments indicated that… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(6 citation statements)
references
References 64 publications
0
6
0
Order By: Relevance
“…[26] Therefore, the Ru II complex may only bind as an end-capping molecule on either lateral loop faces, similar to other reports of Ru II polypyridyl complexes with duplex and Gquadruplex DNA. [10b, 26,30] In this type of binding mode, the dmdppz or dmdppz-Br ligand would only interactw ith one set of guanosines,r ather than two sets in an intercalating binding mode,a nd facilitatethe melting process through atriplex.…”
Section: Resultsmentioning
confidence: 99%
“…[26] Therefore, the Ru II complex may only bind as an end-capping molecule on either lateral loop faces, similar to other reports of Ru II polypyridyl complexes with duplex and Gquadruplex DNA. [10b, 26,30] In this type of binding mode, the dmdppz or dmdppz-Br ligand would only interactw ith one set of guanosines,r ather than two sets in an intercalating binding mode,a nd facilitatethe melting process through atriplex.…”
Section: Resultsmentioning
confidence: 99%
“…With increasing interest in the new antitumor targets G4 and telomerase, a number of ruthenium­(II/III)-based anticancer agents targeting G4 and telomerase such as [Ru­(bpy) 2 (tip)] 2+ and [Ru­(phen) 2 (tip)] 2+ , [(C 6 H 6 )­Ru­( o -ClPIP)­Cl]­Cl, [Ru­(bpy)­(biim)], [Ru­(phen)­(biim)], and [Ru­( p -mopip)­(biim)], [Ru­(bpy)­(pedppz)] and [Ru­(bpy)­(pemitatp)], [Ru­(bpy) 2 (ptpn)] 2+ and [Ru­(pehn) 2 (ptpn)] 2+ , [(η 6 -arene)­Ru­(en)­Cl] + , [Ru­(ip) 3 ]­(ClO 4 ) 2 and [Ru­(pip) 3 ]­(ClO 4 ) 2 , and [(dmb) 2 Ru­(obip)­Ru­(dmb) 2 ] 4+ , have been reported. However, only a few chiral anticancer ruthenium complexes, such as ruthenium­(II) arene PTS (RAPTA) complexes, Λ-[Ru­(phen) 2 ( p -MOPIP)] 2+ and Δ-[Ru­(phen) 2 ( p -MOPIP)] 2+ , [{Ru­(phen) 2 } 2 tpphz] 4+ , Λ-[Ru­(phen) 2 ( p -HPIP)] 2+ , and Δ-[Ru­(phen) 2 ( p -HPIP)] 2+ , which display inhibitory effects on telomerase activity by stabilization of G4-DNA, have been developed.…”
Section: Introductionmentioning
confidence: 99%
“…No in-depth study has been carried out on the interaction of other dinuclear ruthenium(II) complexes bearing a bridging imidazo-phen ligand ( bpibp , pyip , bpip , bpip-CH 3 -OH , bpip-Cz, and tpipib ) with G-quadruplexes, but they have been investigated as potential anti-cancer drugs due to their ability to stabilize G-quadruplex structures [ 263 , 264 , 265 ]. Two examples of trinuclear ruthenium(II) complexes ([{Ru(bpy) 2 } 3 ( tpbip )]6 + and [{Ru(bpy) 2 } 3 ( tptaip )]6 + ) ( Figure 29 ) have also been studied for the same purpose [ 266 ].…”
Section: Interactions Of Ruthenium(ii) Complexes With G-quadruplexesmentioning
confidence: 99%